ArticleWorld journal of hepatology2017

Characterization of a new monoclonal anti-glypican-3 antibody specific to the hepatocellular carcinoma cell line, HepG2.

Preeyanat Vongchan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.